MARK JEROME PYKETT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK JEROME PYKETT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK JEROME PYKETT. MARK JEROME PYKETT is a CEO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a Pres. & CEO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
Address: 425 METRO PLACE NORTH SUITE 450 DUBLIN 43017 OH
Companies in which MARK JEROME PYKETT is an Insider
NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of MARK JEROME PYKETT: Pres. & CEO
Holdings: 402,674 shares
Current Value: $209,390
Latest Transaction: Jan 31 2014
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK JEROME PYKETT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2014 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | CEO | Option Exercise | A | 1.77 | 258,000 | 456,660 | 258,000 | |
| Nov 08 2013 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | CEO | Buy | P | 1.35 | 10,900 | 14,715 | 402,674 | 391.8 K to 402.7 K (+2.78 %) |
| Mar 18 2013 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Buy | P | 2.70 | 1,850 | 4,995 | 355,914 | 354.1 K to 355.9 K (+0.52 %) |
| Mar 15 2013 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Payment of Exercise | F | 3.16 | 43,236 | 136,626 | 354,064 | 397.3 K to 354.1 K (-10.88 %) |
| Mar 15 2013 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Grant | A | 0.00 | 125,000 | 0 | 397,300 | 272.3 K to 397.3 K (+45.91 %) |
| Feb 19 2013 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Option Exercise | A | 3.08 | 304,000 | 936,320 | 304,000 | |
| Feb 19 2013 | NAVB | NAVIDEA BIOPHARMAC ... | PYKETT MARK JEROME | Pres. & CEO | Sell | D | 3.08 | 35,000 | 107,800 | 272,300 | 307.3 K to 272.3 K (-11.39 %) |